ELTS Score and Early "Warning" Define a Two-Stage Risk Framework for Failure-Free Survival in Chronic-Phase CML.

Takagi F, Ono T, Takahashi N, Minami Y, Nakaseko C, Iriyama N, Fujimaki K, Kakihana K, Ogasawara Y, Okada M, Tauchi T, Atsuta Y, Suzuki R, Yamamoto K, Ohtake S, Miyamoto T, Ohnishi K, Sakaida E, Fujisawa S, Kobayashi Y, Kawaguchi T, Kizaki M, Kiyoi H, Miyazaki Y, Matsumura I

Open source

DOI: 10.1182/bloodadvances.2026021073
Published: 2026 Aug 14
Container: Blood advances
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1182/bloodadvances.2026021073,
  title = {ELTS Score and Early "Warning" Define a Two-Stage Risk Framework for Failure-Free Survival in Chronic-Phase CML.},
  author = {Takagi F and Ono T and Takahashi N and Minami Y and Nakaseko C and Iriyama N and Fujimaki K and Kakihana K and Ogasawara Y and Okada M and Tauchi T and Atsuta Y and Suzuki R and Yamamoto K and Ohtake S and Miyamoto T and Ohnishi K and Sakaida E and Fujisawa S and Kobayashi Y and Kawaguchi T and Kizaki M and Kiyoi H and Miyazaki Y and Matsumura I},
  year = {2026},
  journal = {Blood advances},
  doi = {10.1182/bloodadvances.2026021073},
  url = {https://doi.org/10.1182/bloodadvances.2026021073}
}

RIS

TY  - JOUR
TI  - ELTS Score and Early "Warning" Define a Two-Stage Risk Framework for Failure-Free Survival in Chronic-Phase CML.
AU  - Takagi F
AU  - Ono T
AU  - Takahashi N
AU  - Minami Y
AU  - Nakaseko C
AU  - Iriyama N
AU  - Fujimaki K
AU  - Kakihana K
AU  - Ogasawara Y
AU  - Okada M
AU  - Tauchi T
AU  - Atsuta Y
AU  - Suzuki R
AU  - Yamamoto K
AU  - Ohtake S
AU  - Miyamoto T
AU  - Ohnishi K
AU  - Sakaida E
AU  - Fujisawa S
AU  - Kobayashi Y
AU  - Kawaguchi T
AU  - Kizaki M
AU  - Kiyoi H
AU  - Miyazaki Y
AU  - Matsumura I
PY  - 2026
JO  - Blood advances
DO  - 10.1182/bloodadvances.2026021073
UR  - https://doi.org/10.1182/bloodadvances.2026021073
ER  -

APA

F, T., T, O., N, T., Y, M., C, N., N, I., K, F., K, K., Y, O., M, O., T, T., Y, A., R, S., K, Y., S, O., T, M., K, O., E, S., S, F., Y, K., T, K., M, K., H, K., Y, M., & I, M. (2026). ELTS Score and Early "Warning" Define a Two-Stage Risk Framework for Failure-Free Survival in Chronic-Phase CML.. Blood advances. https://doi.org/10.1182/bloodadvances.2026021073

Source records

pubmed · retrieved 2026-09-26T07:00:13.318Z